ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Zyban, Retardtabletten - 30 Tablette(n)
55263001 GlaxoSmithKline AG
Zyban, Retardtabletten27.12.1999
  27.12.1999
Bupropion (N06AX12)08.12.2004
WHO-DDD 
15.30 Tablette(n)
15.02. 
A  
Yes 
IPCI
27.52Yes
    
10 %46.35
7680552630011Synthetika
6070929 
Composition
bupropioni hydrochloridum 150 mg, cellulosum microcristallinum, hypromellosum, cysteini hydrochloridum monohydricum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, E 171, cera carnauba, E 172 pro compresso obducto.
Packungsbestandteile
Delayed release tablets 
 
Active AgentDose
Bupropion Hydrochloride150 mg
BAG: Active AgentDose
Bupropion Hydrochloride150 mg
 
Inactive agentsDoseadditional_information
Cellulosum Microcristallinum  
Cera Carnauba  
Cystein Hydrochloride Monohydrate  
E 171 color.
E 172 color.
Hypromellosum Überzug
Macrogol400  
Magnesii Stearas  
Pro Compresso Obducto  
 
Source
Data was imported : 05.12.2019 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home